(Q35760193)

English

Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial

scientific article published on 17 November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 August 2017

Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial (English)

1 reference

Europe PubMed Central

10 August 2017

psoriatic arthritis

1 reference

based on heuristic

inferred from title

Dafna D. Gladman

8

object named as

D D Gladman

1 reference

Europe PubMed Central

10 August 2017

author name string

A Kavanaugh

1

1 reference

Europe PubMed Central

10 August 2017

G G Krueger

2

1 reference

Europe PubMed Central

10 August 2017

A Beutler

3

1 reference

Europe PubMed Central

10 August 2017

C Guzzo

4

1 reference

Europe PubMed Central

10 August 2017

B Zhou

5

1 reference

Europe PubMed Central

10 August 2017

L T Dooley

6

1 reference

Europe PubMed Central

10 August 2017

P J Mease

7

1 reference

Europe PubMed Central

10 August 2017

K de Vlam

9

1 reference

Europe PubMed Central

10 August 2017

P P Geusens

10

1 reference

Europe PubMed Central

10 August 2017

C Birbara

11

1 reference

Europe PubMed Central

10 August 2017

D G Halter

12

1 reference

Europe PubMed Central

10 August 2017

C Antoni

13

1 reference

Europe PubMed Central

10 August 2017

IMPACT 2 Study Group

14

1 reference

Europe PubMed Central

10 August 2017

language of work or name

0 references

publication date

17 November 2006

1 reference

Europe PubMed Central

10 August 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

10 August 2017

66

1 reference

Europe PubMed Central

10 August 2017

4

1 reference

Europe PubMed Central

10 August 2017

498-505

1 reference

Europe PubMed Central

10 August 2017

Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856065

2 October 2017

Psoriatic arthritis: epidemiology, clinical features, course, and outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856065

2 October 2017

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856065

2 October 2017

TNFalpha therapy in psoriatic arthritis and psoriasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856065

2 October 2017

The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiat

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856065

2 October 2017

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856065

2 October 2017

Severe Psoriasis – Oral Therapy with a New Retinoid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856065

2 October 2017

Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856065

12 July 2018

Epidemiology of psoriatic arthritis in the population of the United States.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856065

25 September 2018

Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856065

25 September 2018

A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856065

25 September 2018

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856065

25 September 2018

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17114188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17114188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of disability and quality of life in rheumatoid and psoriatic arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17114188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17114188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/17114188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid

1 reference

https://pubmed.ncbi.nlm.nih.gov/17114188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality studies in psoriatic arthritis. Results from a single outpatient clinic. I. Causes and risk of death

1 reference

https://pubmed.ncbi.nlm.nih.gov/17114188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of cytokine production in psoriatic synovium

1 reference

https://pubmed.ncbi.nlm.nih.gov/17114188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17114188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TNF Inhibition Rapidly Down-Regulates Multiple Proinflammatory Pathways in Psoriasis Plaques

1 reference

https://pubmed.ncbi.nlm.nih.gov/17114188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine profiles during infliximab monotherapy in psoriatic arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17114188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17114188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective analysis of psoriatic arthritis in patients hospitalized for psoriasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17114188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales

1 reference

https://pubmed.ncbi.nlm.nih.gov/17114188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psoriatic arthritis (PSA)--an analysis of 220 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17114188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/17114188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991

1 reference

https://pubmed.ncbi.nlm.nih.gov/17114188

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ARD.2006.058339

1 reference

Europe PubMed Central

10 August 2017

release_aotc4kiyhjgpbp7orknmso2d6m

1 reference

https://api.fatcat.wiki/v0/release/aotc4kiyhjgpbp7orknmso2d6m

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35760193&oldid=1841528212"